Non-endocrine late complications in children after allogeneic haematopoietic SCT

Bone Marrow Transplantation

Volumn 41, Issue SUPPL. 2, 2008, Pages

  Faraci, M ^a   Bekassy A N ^b   De Fazio, V ^a   Tichelli, A ^c   Dini, G ^a  

^a G GASLINI INSTITUTE   (Italy)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CD20 ANTIBODY; CHICKENPOX VACCINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; DACLIZUMAB; DIPHTHERIA TOXOID; EVEROLIMUS; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INFLUENZA VACCINE; LYMPHOCYTE ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RAPAMYCIN; TACROLIMUS; TETANUS TOXOID; THYMOCYTE ANTIBODY; UNINDEXED DRUG; YELLOW FEVER VACCINE;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AVASCULAR NECROSIS; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHICKENPOX; CHILDHOOD CANCER; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORD BLOOD STEM CELL TRANSPLANTATION; DENTAL CARIES; DIPHTHERIA; DRUG MEGADOSE; EYE DISEASE; FOLLOW UP; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEALTH CARE COST; HEARING IMPAIRMENT; HEART DISEASE; HEMATOLOGIC MALIGNANCY; HEPATITIS B; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INFECTION; INFLUENZA; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; LIVER DISEASE; LUNG TRANSPLANTATION; MEASLES; MENINGOCOCCOSIS; MUMPS; NEUROLOGIC DISEASE; NEUROTOXICITY; ORAL MUCOSAL DISEASE; OSTEOPOROSIS; OTOTOXICITY; PNEUMOCYSTIS PNEUMONIA; POLIOMYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RESPIRATORY FAILURE; RETINOPATHY; REVIEW; RISK FACTOR; RUBELLA; SECOND CANCER; STREPTOCOCCUS INFECTION; T CELL DEPLETION; TETANUS; THORAX RADIOGRAPHY; TOXOPLASMOSIS; VACCINATION; WHOLE BODY RADIATION; YELLOW FEVER;

CHILD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SURVIVORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 45749139340     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.55     Document Type: Review

References (55)

1. www.survivorsshipguidelines.org, 2006.
2. Toubert A. Immune reconstitution after allogeneic HSCT. In: Apperley J, Carreras E, Gluckman E, Gratwohl A, Masszi T (eds). The EBMT Handbook. Haematopoietic Stem Cell Transplantation, 2004 revised edn. European School of Haematology, France, 2004, pp 215-222.
3. Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373-3385.
4. Castagnola E. Dallorso S. Faraci M, Morreale G, Di Martino D, Cristina E et al. Long lasting Hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy. J Hematother Stem Cell Res 2003; 12: 9-10.
5. Rizzo JD, Wingard JR. Tichelli A. Lee SJ. Van Lint MT. Burns LJ et al Recommended screening and preventive practices for long-term survivors after haematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation. Centre for International, Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT CIBMTR ASBMT). Bone Marrow Transplant 2006: 37: 249-261.
6. Ljungman P. Immunization of transplant recipients. Bone Marrow Transplant 1999; 23: 635-636.
7. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C et al Chronic graft-versus-host disease in children: Incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192-1200.
8. www.asbmt.org GVHDForms.htm.
9. Pavletic SZ, Lee SJ, Socié G, Vogelsang G. Chronic graft-versus-host disease: Implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 2006; 38: 645-651.
10. Perruche S, Marandin A. Kleinclauss F, Angoinin R, Fresnay S, Baron MH et al. Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrence. Transplantation 2006; 81: 573-582.
11. Bishop M, Flowers MED, Foss FM, Couriel D. Emerging strategies in the treatment of chronic Graft-versus-Host Disease. Symposium Report. Blood Marrow Transplant Rev 2002; 12: 4-14.
12. Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello G, Cesaro S et al. Extracorporeal photochemotherapy for paediatric patients with graft versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122: 118-127.
13. Griese M, Rampf U, Hofmann D, Füher M, Reinhardt D, Bender-Götze C. Pulmonary complications after bone marrow transplantation in children: Twenty-four years of experience in a single pediatric centre. Pediatr Pulmonol 2000; 30: 393-401.
14. Garaventa A, Rondelli R, Locatelli F, Dallorso S, Porta F, Uderzo C et al. Pneumopathy in children after bone marrow transplantation. Report from the AIEOP-Registry. The Italian Association of Paediatric Hematology-Oncology BMT group. Bone Marrow Transplant 1996; 18 160-162.
15. Cerveri I, Zoia MC, Fulgoni P, Corsico A, Casali L, Tinelli C et al Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999; 54: 131-135.
16. Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F et al. Impact of cumulative anthracycline dose. preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: A prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant 2007; 39: 667-675.
17. Soubani AO, Uberti JP. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J, Review 2007; 29: 1007-1019.
18. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: Part I. Br J Haematol 2002; 118 3-22.
19. Marras TK, Szalai JP, Chan CK, Lipton JH, Messner HA, Laupacis A. Pulmonary function abnormalities after allogeneic marrow transplantation: A systematic review and assessment of an existing predictive instrument. Bone Marrow Transplant 2002; 30: 599-607.
20. Anfessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset-non infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425-434.
21. Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiation Biol Phys 2005; 63: 1568-1575.
22. Liesner RJ, Leiper AD, Hama IM, Chessells JM. Late effects of intensive treatment for acute myeloid leukaemia and myelodysplasia in childhood. J Clin Oncol 1999; 12: 916-924.
23. Donat J. The postmenopausal estrogen deficiency syndrome and hormone replacement therapy. Cas Lek Cesk 1997; 11: 343-347.
24. Slalitin S, Philipp M, Stein J, Goshen Y, Carmi D, Yaniv I. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 2006; 12: 1109-1117.
25. Holmstrmg G, Borg Strom B, Calisserndorff B. Cataract in children after bone marrow transplantation: Relation to conditioning regimen. Acta Ophthalmol Scand 2002; 80: 211-215.
26. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: Part II. Br J Haematol 2002; 118 23-43.
27. Tichelli A, Gratwohl A, Egger T, Roth J, Prunte A, Niessen C et al Cataract formation after bone marrow transplantation. Ann Intern Med 1993; 12: 1175-1180.
28. Bylsma GW, Hall A, Szer J, West R. Atypical retinal microvasculopathy after bone marrow transplantation. Clin Exp Ophthalmol 2001; 29 225-229.
29. Dahllöf G, Barr M, Bolme P, Modéer T, Lönnqvist B, Ringdén O et al. Disturbance in dental development after TBI in bone marrow recipients. Oral Surg Oral Med Oral Pathol 1988; 65: 41-44.
30. Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ. Bone Marrow transplantation in children: Consequences for renal function shortly after and 1 year post BMT. Bone Marrow Transplant 1998; 22: 559-564.
31. Lönnerholm G, Carlson K, Bratteby LE, Backlund L, Hagberg H. Rikner G et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 129-134.
32. Cohen EP, Lawtonca A, Moulder JE. Bone marrow transplantation nephropathy: Radiation nephritis revisited. Nephron 1995; 70 217-222.
33. Frisk P, Bratteby LE, Carlson K, Lonnerholm G. Renal function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplant 2002; 29: 129-136.
34. Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastors B et al Renal toxicity after allogeneic bone marrow transplantation: The combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 1996; 2: 579-585.
35. Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch G et al. Cirrhosis of the liver in long term marrow transplant survivors. Blood 1999; 10: 3259-3266.
36. Ho GT, Parker A, MacKenzie JF, Morris AJ. Stanley AJ. Abnormal liver function tests following bone marrow transplantation: Aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol 2004; 16: 157-162.
37. Meo A, Ruggeri A, La Rosa MA, Zanghi L, Morabito N, Duca L. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation. Hemoglobin 2006; 30: 131-137.
38. Mattano L. The skeletal remains: Porosis and necrosis of bone in the marrow transplantation setting. Pediatr Transplant 2003; 7: 71-75.
39. Socié G, Cahn Y, Carmelo J, Vernant JP, Jouet JP, Ifrah N et al Avascular necrosis of bone after allogeneic bone marrow transplantation: Analysis of risk factors for 4388 patients by the Societé Francaise de Greffe de Moëlle (SFGM). Br J Haematol 1997; 97: 865-870.
40. Torii Y, Hasegawas Y, Kubo T, Kodera Y, Minami S, Morishita Y et al Osteonecrosis of the femoral head after allogeneic bone marrow transplantation. Clin Orthopaed Rel Res 2001; 382: 124-132.
41. Enright H, Haake R, Weisdorf D. Avascular necrosis of bone: A common serious complication of allogeneic bone marrow transplantation. Am J Med 1990; 89: 733-738.
42. Socié G, Selimi F, Sedel L, Frija J, Devergie A, Espperou Bourdeau H. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol 1994; 86: 624-628.
43. Faraci M, Calevo MG, Caruso S, Lanino E, Messina C, Favre C et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control Study in Italy. Haematologica 2006; 91: 1096-1099.
44. Gangji V, Hauzeur JP, Matos C, Maertelaer V, Toungouz M. Autologous bone-marrow cells. A pilot study treatment of osteonecrosis of the femoral head with implantation. J Bone Joint Surg Am 2004; 86 1153-1160.
45. Schimmer A. Mindem M, Keating A. Osteoporosis after blood and marrow transplantation: Clinical aspects. Biol Blood Marrow Transplant 2000; 6: 175-181.
46. Weilbaecher KN. Mechanism of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000; 6: 165-174.
47. Baker SK, Defor TE, Burns L, Ramsay NKC, Neglia JP, Robison L. New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors. J Clin Oncol 2003; 21 1352-1358.
48. Curtis R, Rowlings PA, Deeg HJ, Shriner DA, Socié G, Travis SH et al. Solid cancers after bone marrow transplantation. New Eng J Med 1997; 336: 897-904.
49. Bhatia S, Landier W. Evaluating survivors of pediatric cancer. Cancer J 2005; 11: 340-354.
50. Sociè G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis B. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348-357.
51. Phipps S, Dunavant M, Srivastava D, Bowman L, Mulhern RK. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000; 18: 1004-1011.
52. Faraci M, Lanino E, Dallorso S, Morreale G, Cappelli B, Gaggero R et al. Mesial temporal sclerosis - a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity. Bone Marrow Transplant 2003; 31: 919-922.
53. Faraci M, Lanino E, Dini G, Fondelli MP, Morreale G, Dallorso S et al Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002; 59: 1895-1904.
54. Felder Puig R, di Gallo A, Waldenmair M, Norden P, Winter A, Gadner H et al. Health-related quality of life in pediatric patients receiving allcrgeneic stem cell or bone marrow transplantation: Results of a longitudinal, multi-centre study. Bone Marrow Transplant 2006; 38: 119-126.
55. Felder Puig R, Peters C, Matthes-Martin S, Lamche M, Felsberger C, Gadner H et al. Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 75-80.